Skip to search formSkip to main contentSkip to account menu

CGP 56999A

Known as: CGP-56999A, CGP56999A 
National Institutes of Health

Related topics

Related topics

2 relations
CGP 56999

Broader (1)

Phosphinic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
GABAB receptor blockade in the hippocampus affects sensory and sensorimotor gating in Long-Evans rats
RationaleSensory and sensorimotor gating deficits are observed in schizophrenia. GABAB receptor deficiency is also detected in… 
2010
2010
Seizures in the developing brain result in a long-lasting decrease in GABAB inhibitory postsynaptic currents in the rat hippocampus
2005
2005
Hippocampal Afterdischarges after GABAB‐Receptor Blockade in the Freely Moving Rat
Summary:  Purpose: To determine whether hippocampal afterdischarges (ADs) and excitability changes were induced by γ‐aminobutyric… 
2003
2003
Gamma-hydroxybutyrate reduces mitogen-activated protein kinase phosphorylation via GABA B receptor activation in mouse frontal cortex and hippocampus.
gamma-Hydroxybutyrate (GHB) naturally occurs in the brain, but its exogenous administration induces profound effects on the… 
1998
1998
Morpholin-2-yl-phosphinic acids are potent GABA(B) receptor antagonists in rat brain.
1997
1997
Comparative in vivo and in vitro studies with the potent GABAB receptor antagonist, CGP 56999A.
1996
1996
Synaptic inhibition mediated by GABAB receptors in the neonatal rat spinal cord in vitro
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)